Resources Contact Us Home
Modified factor VIII

Image Number 3 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Method of manufacturing nitride semiconductor and nitride semiconductor element
Resin composition, prepreg, resin sheet, metal-clad laminate, printed wiring board, multilayer printed wiring board and semiconductor device
Electronic communication device
Event handling in an integrated execution environment
Firewall-tolerant voice-over-internet-protocol (VoIP) emulating SSL or HTTP sessions embedding voice data in cookies
Discharge lamp comprising coated electrode
Timing controller capable of removing surge signal and display apparatus including the same
  Randomly Featured Patents
Color thermosensitive printer and optical fixing device therefor
Positioning guide for rubber-like material rotary cutting machine
Brazing alloy
Multiplex stereo demodulator
Broom cap
Key arrangements and methods of use
Ultrasonic horn, and ultrasonic bonding apparatus using the ultrasonic horn
Optical shared protection ring for multiple spans
Vapor phase catalytic oxidation and/or ammoxidation of cyclohexanone and/or cyclohexanol to phenol and/or aniline
Hearing aid with integrated retrieval line and volume control